Related News

May 11, 2020

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $93.26 to a high of $97.49. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $96.59 on...

April 27, 2020

SmarTrend identified an Uptrend for Biomarin Pharmac (NASDAQ:BMRN) on March 25th, 2020 at $80.09. In approximately 1 month, Biomarin Pharmac has returned 21.79% as of today's recent price of $97.54.

In the...

April 20, 2020

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $87.77 to a high of $91.67. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $89.16 on...

April 16, 2020

SmarTrend identified an Uptrend for Biomarin Pharmac (NASDAQ:BMRN) on March 25th, 2020 at $80.09. In approximately 3 weeks, Biomarin Pharmac has returned 6.31% as of today's recent price of $85.14.

In the...

April 14, 2020

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $83.95 to a high of $85.68. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $83.50 on...

April 11, 2020

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks...

April 7, 2020

Today, shares of Biomarin Pharmac (NASDAQ:BMRN) have crossed bullishly above their 10-day moving average of $82.93 on a volume of 173K shares. Swing traders may find an opportunity for a long position, as such a...

April 2, 2020

Below are the three companies in the Biotechnology industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and...

April 2, 2020

Below are the three companies in the Biotechnology industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and...

March 30, 2020

Below are the three companies in the Biotechnology industry with the highest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. Generally, the lower the PEG, the...